These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 806708
1. The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report. Hisazumi H, Uchibayashi T, Naito K, Misaki T, Miyazaki K. J Urol; 1975 Sep; 114(3):394-8. PubMed ID: 806708 [Abstract] [Full Text] [Related]
2. Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder. Gavrell GJ, Lewis RW, Meehan WL, Leblanc GA. J Urol; 1978 Oct; 120(4):410-1. PubMed ID: 100615 [Abstract] [Full Text] [Related]
3. Anticancer drug sensitivity in vitro in the bladder cancer cell line, KK-47 and prophylactic use of carbazilquinone and urokinase in bladder cancer. Hisazumi H, Uchibayashi T, Katoh M, Kobayashi T, Nakajima K, Naitoh K, Misaki T, Kuroda K. Urol Res; 1981 Oct; 9(5):231-5. PubMed ID: 7029855 [Abstract] [Full Text] [Related]
4. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors. Mukamel E, Zitron S, Nissenkorn I, Servadio C. Isr J Med Sci; 1980 Oct; 16(9-10):714-6. PubMed ID: 6776072 [Abstract] [Full Text] [Related]
5. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder]. Toulouse J, Bouffier B, Etievent JP, Bittard M. J Urol (Paris); 1983 Oct; 89(2):85-9. PubMed ID: 6408192 [Abstract] [Full Text] [Related]
6. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa. Nocks BN, Nieh PT, Prout GR. J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947 [Abstract] [Full Text] [Related]
7. The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder. Wescott JW. J Urol; 1966 Dec; 96(6):913-8. PubMed ID: 4959545 [No Abstract] [Full Text] [Related]
13. [Clinical research on prevention of recurrence of superficial bladder cancer--comparative study on clinical efficacy of bleomycin intravesical instillation and bestatin]. Kumamoto Y, Tsukamoto T, Tamiya T, Takatsuka K, Furuya S, Yokoyama E, Honma A, Aoyama T, Tanda H, Kato S. Hinyokika Kiyo; 1985 Oct; 31(10):1861-83. PubMed ID: 2418659 [Abstract] [Full Text] [Related]
14. Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma. Brosman SA. J Urol; 1982 Jul; 128(1):27-30. PubMed ID: 6809960 [Abstract] [Full Text] [Related]
16. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation]. Wang SH. Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342 [Abstract] [Full Text] [Related]
17. A comparison of treatment methods for the prophylaxis of recurrent superficial bladder tumors. Rodrigues Netto Júnior N, Lemos GC. J Urol; 1983 Jan; 129(1):33-4. PubMed ID: 6402610 [Abstract] [Full Text] [Related]
18. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma]. Zhang SX, Deng XZ, Tang XD. Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180 [No Abstract] [Full Text] [Related]
19. The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours. Dobrzecki W, Kaczmarek A. Int Urol Nephrol; 1977 Aug; 9(2):145-9. PubMed ID: 412808 [Abstract] [Full Text] [Related]
20. [Prophylactic chemotherapy of transitional cell carcinoma of the bladder: the efficacy of long-term bladder instillation]. Maru A, Nantani M, Koyanagi T, Ohashi N, Yamada T, Fujieda J, Omuro H, Nishida T, Kusakai Y, Amino I. Nihon Hinyokika Gakkai Zasshi; 1986 Jul; 77(7):1089-98. PubMed ID: 3784197 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]